MedicaidAdministrativeMedium impact
Spring Provider Newsletter
South Dakota Medicaid·SD·Education
Effective date
May 15, 2026
We identified it
Jun 21, 2026
Summary
South Dakota Medicaid is implementing a new biosimilar preferred drug list for physician-administered drugs effective May 15, 2026, and updating hospital reimbursement methodologies from MS-DRG to APR-DRG effective July 1, 2026. Providers must also ensure their enrollment information is current as the state transitions to a new credentialing system.
Action Required
By May 15, 2026: Review the new physician-administered drug biosimilar PDL on the SD Medicaid website and update prescribing practices to prefer biosimilar products when available. By July 1, 2026: Prepare billing systems for transition from MS-DRG to APR-DRG for inpatient hospital claims. Immediately: Login to the Provider Enrollment Portal to verify and update all provider information before the new SD PECS system launches.